CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income	$ 3,486,000,000	$ 4,640,000,000
Less: Net income attributable to the noncontrolling interest	66,000,000	59,000,000
Net income attributable to Honeywell	3,420,000,000	4,581,000,000
Adjustments to reconcile net income attributable to Honeywell to net cash provided by operating activities:
Depreciation	480,000,000	500,000,000
Amortization	268,000,000	319,000,000
Repositioning and other charges	486,000,000	306,000,000
Net payments for repositioning and other charges	(652,000,000)	(157,000,000)
Pension and other postretirement income	(633,000,000)	(484,000,000)
Pension and other postretirement benefit payments	(37,000,000)	(50,000,000)
Stock compensation expense	118,000,000	112,000,000
Deferred income taxes	(289,000,000)	(298,000,000)
Reimbursement receivables charge	350,000,000	0
Other	(369,000,000)	98,000,000
Changes in assets and liabilities, net of the effects of acquisitions and divestitures:
Accounts receivable	615,000,000	(78,000,000)
Inventories	(284,000,000)	(276,000,000)
Other current assets	246,000,000	(68,000,000)
Accounts payable	(460,000,000)	(89,000,000)
Accrued liabilities	167,000,000	(133,000,000)
Net cash provided by (used for) operating activities	3,426,000,000	4,283,000,000
Cash flows from investing activities:
Expenditures for property, plant and equipment	(615,000,000)	(504,000,000)
Proceeds from disposals of property, plant and equipment	17,000,000	41,000,000
Increase in investments	(2,371,000,000)	(3,218,000,000)
Decrease in investments	2,634,000,000	3,318,000,000
Receipts (payments) from settlements of derivative contracts	(75,000,000)	245,000,000
Other	0	(4,000,000)
Net cash provided by (used for) investing activities	(410,000,000)	(122,000,000)
Cash flows from financing activities:
Proceeds from issuance of commercial paper and other short-term borrowings	8,577,000,000	10,292,000,000
Payments of commercial paper and other short-term borrowings	(8,512,000,000)	(10,293,000,000)
Proceeds from issuance of common stock	163,000,000	425,000,000
Proceeds from issuance of long-term debt	10,105,000,000	2,725,000,000
Payments of long-term debt	(4,237,000,000)	(120,000,000)
Repurchases of common stock	(2,149,000,000)	(3,650,000,000)
Cash dividends paid	(1,921,000,000)	(1,798,000,000)
Other	(54,000,000)	(72,000,000)
Net cash provided by (used for) financing activities	1,972,000,000	(2,491,000,000)
Effect of foreign exchange rate changes on cash and cash equivalents	(19,000,000)	(49,000,000)
Net increase (decrease) in cash and cash equivalents	4,969,000,000	1,621,000,000
Cash and cash equivalents at beginning of period	9,067,000,000	9,287,000,000
Cash and cash equivalents at end of period	$ 14,036,000,000	$ 10,908,000,000